Marwân-Al-Qays Bousmah

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Antiretroviral Therapy

Health Insurance

Top Venues

BMC health services research

Open forum infectious diseases

BMJ global health

Journal of acquired immune deficiency syndromes (1999)

This page only lists publications with an associated author ORCID identifier.

Publications

Bianca Gonçalves Tasca, Marwân-Al-Qays Bousmah, Karna Coulibaly, Anne Gosselin, Andrainolo Ravalihasy, Annabel Desgrées du Loû, Maria Melchior, null null
Depression and loneliness among Sub-Saharan immigrants living in the greater Paris area: results from the MAKASI empowerment stepped wedge cluster randomised controlled trial. Social psychiatry and psychiatric epidemiology (2024)
Marwân-Al-Qays Bousmah, Camelia Protopopescu, Mireille Mpoudi-Etame, Pierrette Omgba Bassega, Gwenaëlle Maradan, Justin Olinga, Marie Varloteaux, Tamara Tovar-Sanchez, Éric Delaporte, Charles Kouanfack, Sylvie Boyer, null null
Improvements in patient-reported outcomes following initiation of dolutegravir- or low-dose efavirenz-based first-line antiretroviral therapy: A four-year longitudinal analysis in Cameroon (NAMSAL ANRS 12313 trial). Journal of acquired immune deficiency syndromes (1999) (2023)
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, Pierrette Omgba Bassega, Justin Olinga, Eric Mimbe, Michel Foalem, Camille Chiep, Serge Edimo, Marie Varloteaux, Raphaël Pelloquin, Nadine Lamare, Sylvie Boyer, Martine Peeters, Jacques Reynes, Alexandra Calmy, Andrew Hill, Eric Delaporte, Charles Kouanfack, null null
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Open forum infectious diseases 10 (12) (2023)
Marion Coste, Marwân-Al-Qays Bousmah
Predicting health services utilization using a score of perceived barriers to medical care: evidence from rural Senegal. BMC health services research 23 (1) (2023)
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, Pierrette Omgba Bassega, Justin Olinga, Eric Mimbe, Michel Foalem, Camille Chiep, Serge Edimo, Marie Varloteaux, Raphaël Pelloquin, Nadine Lamare, Sylvie Boyer, Martine Peeters, Jacques Reynes, Alexandra Calmy, Andrew Hill, Eric Delaporte, Charles Kouanfack, null null
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Open forum infectious diseases 10 (12) (2023)
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, Pierrette Omgba Bassega, Justin Olinga, Eric Mimbe, Michel Foalem, Camille Chiep, Serge Edimo, Marie Varloteaux, Raphaël Pelloquin, Nadine Lamare, Sylvie Boyer, Martine Peeters, Jacques Reynes, Alexandra Calmy, Andrew Hill, Eric Delaporte, Charles Kouanfack, null null
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Open forum infectious diseases 10 (12) (2023)
Marion Coste, Marwân-Al-Qays Bousmah
Predicting health services utilization using a score of perceived barriers to medical care: evidence from rural Senegal. BMC health services research 23 (1) (2023)
Marion Coste, Marwân-Al-Qays Bousmah
Predicting health services utilization using a score of perceived barriers to medical care: evidence from rural Senegal. BMC health services research 23 (1) (2023)
Marwân-Al-Qays Bousmah, Camelia Protopopescu, Mireille Mpoudi-Etame, Pierrette Omgba Bassega, Gwenaëlle Maradan, Justin Olinga, Marie Varloteaux, Tamara Tovar-Sanchez, Éric Delaporte, Charles Kouanfack, Sylvie Boyer, null null
Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). Journal of acquired immune deficiency syndromes (1999) 94 (3) (2023)
Marwân-Al-Qays Bousmah, Pathé Diakhaté, Grâce À Dieu Toulao, Jean-Yves Le Hesran, Richard Lalou
Effects of a free health insurance programme for the poor on health service utilisation and financial protection in Senegal. BMJ global health 7 (Suppl 9) (2022)
Marwân-Al-Qays Bousmah, Pathé Diakhaté, Grâce À Dieu Toulao, Jean-Yves Le Hesran, Richard Lalou
Effects of a free health insurance programme for the poor on health service utilisation and financial protection in Senegal. BMJ global health 7 (Suppl 9) (2022)
Marwân-Al-Qays Bousmah, Pathé Diakhaté, Grâce À Dieu Toulao, Jean-Yves Le Hesran, Richard Lalou
Effects of a free health insurance programme for the poor on health service utilisation and financial protection in Senegal. BMJ global health 7 (Suppl 9) (2022)
Ahcène Zehnati, Marwân-Al-Qays Bousmah, Mohammad Abu-Zaineh
Public-private differentials in health care delivery: the case of cesarean deliveries in Algeria. International journal of health economics and management 21 (3) (2021)
Marwân-Al-Qays Bousmah, Marie Libérée Nishimwe, Christopher Kuaban, Sylvie Boyer
Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon. BMC health services research 21 (1) (2021)
Sawsan Abdulrahim, Marwân-Al-Qays Bousmah
Regional Inequalities in Maternal and Neonatal Health Services in Iraq and Syria From 2000 to 2011. International journal of health services : planning, administration, evaluation 49 (3) (2019)